Last 12 months
Inside the activity.
0 purchase rows · 46 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 7 |
| Dec 2025 | 0 | 9 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 15 |
| Aug 2026 | 0 | 5 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 16, 2025 Filed Sep 18, 2025 20:06 UTC |
Denton Sheila A.EVP & General Counsel
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 278 | $0.00 Strike: $64.25 | $0.00 |
DisclosureSEC source: 0001995298-25-000006 · wk-form4_1758225978.xml · derivative · entry 3 Denton Sheila A. · CIK 0001995298 · EVP & General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,438 Underlying: Common Stock · 278 shares Expires 2034-07-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The July 15, 2024 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years. Read SEC document |
| September 16, 2025 Filed Sep 18, 2025 20:06 UTC |
Denton Sheila A.EVP & General Counsel
|
SaleCommon Stock | 278 | $83.15 | $23,115.70 |
DisclosureSEC source: 0001995298-25-000006 · wk-form4_1758225978.xml · nonDerivative · entry 2 Denton Sheila A. · CIK 0001995298 · EVP & General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,200 F1 · balance_after: This includes an aggregate of 32,544 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance units that have not vested. Read SEC document |
| September 16, 2025 Filed Sep 18, 2025 20:06 UTC |
Denton Sheila A.EVP & General Counsel
|
Exercise / conversionCommon Stock | 278 | $64.25 | $17,861.50 |
DisclosureSEC source: 0001995298-25-000006 · wk-form4_1758225978.xml · nonDerivative · entry 1 Denton Sheila A. · CIK 0001995298 · EVP & General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,478 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 02, 2025 Filed Sep 4, 2025 20:04 UTC |
Denton Sheila A.EVP & General Counsel
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 598 | $0.00 Strike: $58.06 | $0.00 |
DisclosureSEC source: 0001995298-25-000004 · wk-form4_1757016265.xml · derivative · entry 3 Denton Sheila A. · CIK 0001995298 · EVP & General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 14,962 Underlying: Common Stock · 598 shares Expires 2033-10-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Beginning October 2, 2023, options become exercisable in 37 installments, with the first 25% vesting on October 2, 2024 and the remainder vesting monthly over three years. Read SEC document |
| September 02, 2025 Filed Sep 4, 2025 20:04 UTC |
Denton Sheila A.EVP & General Counsel
|
SaleCommon Stock | 598 | $84.97 | $50,812.06 |
DisclosureSEC source: 0001995298-25-000004 · wk-form4_1757016265.xml · nonDerivative · entry 2 Denton Sheila A. · CIK 0001995298 · EVP & General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,200 F1 · balance_after: This includes an aggregate of 32,544 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance units that have not vested. Read SEC document |
| September 02, 2025 Filed Sep 4, 2025 20:04 UTC |
Denton Sheila A.EVP & General Counsel
|
Exercise / conversionCommon Stock | 598 | $58.06 | $34,719.88 |
DisclosureSEC source: 0001995298-25-000004 · wk-form4_1757016265.xml · nonDerivative · entry 1 Denton Sheila A. · CIK 0001995298 · EVP & General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,798 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 25, 2025 Filed Aug 27, 2025 20:43 UTC |
Basi Ramitpal KEVP, Human Resources
|
GrantEmployee Stock Option (right to buy) · Derivative | 29,230 | $0.00 Strike: $84.76 | $0.00 |
DisclosureSEC source: 0002083591-25-000004 · wk-form4_1756327397.xml · derivative · entry 3 Basi Ramitpal K · CIK 0002083591 · EVP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,230 Underlying: Common Stock · 29,230 shares Expires 2035-08-24 F4 · derivative.exercise_date: The August 25, 2025 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years. Read SEC document |
| August 25, 2025 Filed Aug 27, 2025 20:43 UTC |
Basi Ramitpal KEVP, Human Resources
|
GrantPerformance Shares · Derivative | 16,265 | $0.00 | $0.00 |
DisclosureSEC source: 0002083591-25-000004 · wk-form4_1756327397.xml · derivative · entry 2 Basi Ramitpal K · CIK 0002083591 · EVP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,265 Underlying: Common Stock · 16,265 shares Expires 2028-08-25 F3 · derivative.exercise_price: Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return ("TSR") over a three-year performance period beginning on January 1, 2025 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date subject to the Reporting Person's continued service with the issuer. F3 · derivative.exercise_date: Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return ("TSR") over a three-year performance period beginning on January 1, 2025 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date subject to the Reporting Person's continued service with the issuer. Read SEC document |
| August 25, 2025 Filed Aug 27, 2025 20:43 UTC |
Basi Ramitpal KEVP, Human Resources
|
GrantCommon Stock | 6,506 | $0.00 | $0.00 |
DisclosureSEC source: 0002083591-25-000004 · wk-form4_1756327397.xml · nonDerivative · entry 1 Basi Ramitpal K · CIK 0002083591 · EVP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,506 F1 · shares: Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years. The RSUs may be settled only for shares of common stock on a one-for-one basis. F2 · balance_after: Includes the August 25, 2025 aggregate grant of 6,506 shares of common stock. Read SEC document |
| August 15, 2025 Filed Aug 19, 2025 20:13 UTC |
Denton Sheila A.EVP & General Counsel
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 277 | $0.00 Strike: $64.25 | $0.00 |
DisclosureSEC source: 0000879169-25-000109 · wk-form4_1755634387.xml · derivative · entry 3 Denton Sheila A. · CIK 0001995298 · EVP & General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,716 Underlying: Common Stock · 277 shares Expires 2034-07-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The July 15, 2024 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years. Read SEC document |
| August 15, 2025 Filed Aug 19, 2025 20:13 UTC |
Denton Sheila A.EVP & General Counsel
|
SaleCommon Stock | 277 | $86.81 | $24,046.37 |
DisclosureSEC source: 0000879169-25-000109 · wk-form4_1755634387.xml · nonDerivative · entry 2 Denton Sheila A. · CIK 0001995298 · EVP & General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,200 F1 · balance_after: This includes an aggregate of 32,544 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance units that have not vested. Read SEC document |
| August 15, 2025 Filed Aug 19, 2025 20:13 UTC |
Denton Sheila A.EVP & General Counsel
|
Exercise / conversionCommon Stock | 277 | $64.25 | $17,797.25 |
DisclosureSEC source: 0000879169-25-000109 · wk-form4_1755634387.xml · nonDerivative · entry 1 Denton Sheila A. · CIK 0001995298 · EVP & General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,477 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 04, 2025 Filed Aug 6, 2025 20:03 UTC |
Denton Sheila A.EVP & General Counsel
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 598 | $0.00 Strike: $58.06 | $0.00 |
DisclosureSEC source: 0000879169-25-000106 · wk-form4_1754510586.xml · derivative · entry 3 Denton Sheila A. · CIK 0001995298 · EVP & General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,560 Underlying: Common Stock · 598 shares Expires 2033-10-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Beginning October 2, 2023, options become exercisable in 37 installments, with the first 25% vesting on October 2, 2024 and the remainder vesting monthly over three years. Read SEC document |
| August 04, 2025 Filed Aug 6, 2025 20:03 UTC |
Denton Sheila A.EVP & General Counsel
|
SaleCommon Stock | 598 | $75.77 | $45,310.46 |
DisclosureSEC source: 0000879169-25-000106 · wk-form4_1754510586.xml · nonDerivative · entry 2 Denton Sheila A. · CIK 0001995298 · EVP & General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,200 F1 · balance_after: This includes an aggregate of 32,544 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance units that have not vested. Read SEC document |
| August 04, 2025 Filed Aug 6, 2025 20:03 UTC |
Denton Sheila A.EVP & General Counsel
|
Exercise / conversionCommon Stock | 598 | $58.06 | $34,719.88 |
DisclosureSEC source: 0000879169-25-000106 · wk-form4_1754510586.xml · nonDerivative · entry 1 Denton Sheila A. · CIK 0001995298 · EVP & General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,798 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 21, 2025 Filed Jul 23, 2025 19:56 UTC |
Stein Steven HEVP & Chief Medical Officer
|
SaleCommon Stock | 3,706 | $67.94 | $251,785.64 |
DisclosureSEC source: 0000879169-25-000095 · wk-form4_1753300580.xml · nonDerivative · entry 1 Stein Steven H · CIK 0001673776 · EVP & Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 102,886 F1 · balance_after: This includes an aggregate of 100,327 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance shares that have not vested. Read SEC document |
| July 16, 2025 Filed Jul 17, 2025 20:06 UTC |
Flannelly Barry PEVP & General Manager US
|
SaleCommon Stock | 1,340 | $68.36 | $91,602.40 |
DisclosureSEC source: 0000879169-25-000093 · wk-form4_1752782756.xml · nonDerivative · entry 1 Flannelly Barry P · CIK 0001615842 · EVP & General Manager US 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 35,149 F1 · balance_after: This includes an aggregate of 35,136 shares of common stock issuable pursuant to previously reported RSUs and earned performance shares that have not vested. Read SEC document |
| July 16, 2025 Filed Jul 17, 2025 20:05 UTC |
Iyengar Vijay KEVP, GMAPPS
|
SaleCommon Stock | 983 | $68.36 | $67,197.88 |
DisclosureSEC source: 0000879169-25-000092 · wk-form4_1752782723.xml · nonDerivative · entry 1 Iyengar Vijay K · CIK 0001670000 · EVP, GMAPPS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 40,540 F1 · balance_after: This includes an aggregate of 37,752 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested. Read SEC document |
| July 16, 2025 Filed Jul 17, 2025 20:04 UTC |
Denton Sheila A.EVP & General Counsel
|
SaleCommon Stock | 785 | $68.36 | $53,662.60 |
DisclosureSEC source: 0000879169-25-000091 · wk-form4_1752782690.xml · nonDerivative · entry 5 Denton Sheila A. · CIK 0001995298 · EVP & General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,200 F3 · balance_after: Including the July 15, 2025 grant, this includes an aggregate of 32,544 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance units that have not vested. Read SEC document |
| July 15, 2025 Filed Jul 16, 2025 20:05 UTC |
CAGNONI PABLO JPresident, R&D
|
GrantEmployee Stock Option (right to buy) · Derivative | 39,471 | $0.00 Strike: $68.25 | $0.00 |
DisclosureSEC source: 0000879169-25-000086 · wk-form4_1752696353.xml · derivative · entry 5 CAGNONI PABLO J · CIK 0001205703 · President, R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,471 Underlying: Common Stock · 39,471 shares Expires 2035-07-14 F5 · derivative.exercise_date: The July 15, 2025 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years. Read SEC document |
| July 15, 2025 Filed Jul 16, 2025 20:05 UTC |
CAGNONI PABLO JPresident, R&D
|
GrantPerformance Shares · Derivative | 43,846 | $0.00 | $0.00 |
DisclosureSEC source: 0000879169-25-000086 · wk-form4_1752696353.xml · derivative · entry 4 CAGNONI PABLO J · CIK 0001205703 · President, R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,846 Underlying: Common Stock · 43,846 shares Expires 2028-07-15 F4 · derivative.exercise_price: Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return ("TSR") over a three-year performance period beginning on January 1, 2025 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date subject to the Reporting Person's continued service with the issuer. F4 · derivative.exercise_date: Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return ("TSR") over a three-year performance period beginning on January 1, 2025 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date subject to the Reporting Person's continued service with the issuer. Read SEC document |
| July 15, 2025 Filed Jul 16, 2025 20:05 UTC |
CAGNONI PABLO JPresident, R&D
|
GrantCommon Stock | 17,538 | $0.00 | $0.00 |
DisclosureSEC source: 0000879169-25-000086 · wk-form4_1752696353.xml · nonDerivative · entry 3 CAGNONI PABLO J · CIK 0001205703 · President, R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 234,800 F2 · shares: Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years. The RSUs may be settled only for shares of common stock on a one-for-one basis. F3 · balance_after: Including the July 15, 2025 grant, this includes an aggregate of 229,661 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested. Read SEC document |
| July 15, 2025 Filed Jul 16, 2025 20:05 UTC |
CAGNONI PABLO JPresident, R&D
|
Tax withholdingCommon Stock | 2,628 | $68.25 | $179,361.00 |
DisclosureSEC source: 0000879169-25-000086 · wk-form4_1752696353.xml · nonDerivative · entry 2 CAGNONI PABLO J · CIK 0001205703 · President, R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 217,262 F1 · shares: Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of restricted stock units previously reported in Table I as common stock. Read SEC document |
| July 15, 2025 Filed Jul 16, 2025 20:05 UTC |
Stein Steven HEVP & Chief Medical Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 27,629 | $0.00 Strike: $68.25 | $0.00 |
DisclosureSEC source: 0000879169-25-000085 · wk-form4_1752696308.xml · derivative · entry 6 Stein Steven H · CIK 0001673776 · EVP & Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,629 Underlying: Common Stock · 27,629 shares Expires 2035-07-14 F5 · derivative.exercise_date: The July 15, 2025 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years. Read SEC document |
| July 15, 2025 Filed Jul 16, 2025 20:05 UTC |
Stein Steven HEVP & Chief Medical Officer
|
GrantPerformance Shares · Derivative | 30,692 | $0.00 | $0.00 |
DisclosureSEC source: 0000879169-25-000085 · wk-form4_1752696308.xml · derivative · entry 5 Stein Steven H · CIK 0001673776 · EVP & Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 30,692 Underlying: Common Stock · 30,692 shares Expires 2028-07-15 F4 · derivative.exercise_price: Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return ("TSR") over a three-year performance period beginning on January 1, 2025 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date subject to the Reporting Person's continued service with the issuer. F4 · derivative.exercise_date: Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return ("TSR") over a three-year performance period beginning on January 1, 2025 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date subject to the Reporting Person's continued service with the issuer. Read SEC document |
| July 15, 2025 Filed Jul 16, 2025 20:05 UTC |
Stein Steven HEVP & Chief Medical Officer
|
GrantCommon Stock | 12,277 | $0.00 | $0.00 |
DisclosureSEC source: 0000879169-25-000085 · wk-form4_1752696308.xml · nonDerivative · entry 4 Stein Steven H · CIK 0001673776 · EVP & Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 106,592 F2 · shares: Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years. The RSUs may be settled only for shares of common stock on a one-for-one basis. F3 · balance_after: Including the July 15, 2025 grant, this includes an aggregate of 100,327 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance shares that have not vested. Read SEC document |
| July 15, 2025 Filed Jul 16, 2025 20:05 UTC |
Stein Steven HEVP & Chief Medical Officer
|
Tax withholdingCommon Stock | 1,596 | $68.25 | $108,927.00 |
DisclosureSEC source: 0000879169-25-000085 · wk-form4_1752696308.xml · nonDerivative · entry 3 Stein Steven H · CIK 0001673776 · EVP & Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 94,315 F1 · shares: Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of RSUs or earned performance shares previously reported in Table I as common stock. Read SEC document |
| July 15, 2025 Filed Jul 16, 2025 20:03 UTC |
Stamoulis ChristianaEVP & Chief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 24,998 | $0.00 Strike: $68.25 | $0.00 |
DisclosureSEC source: 0000879169-25-000083 · wk-form4_1752696234.xml · derivative · entry 5 Stamoulis Christiana · CIK 0001502917 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,998 Underlying: Common Stock · 24,998 shares Expires 2035-07-14 F5 · derivative.exercise_date: The July 15, 2025 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years. Read SEC document |
| July 15, 2025 Filed Jul 16, 2025 20:03 UTC |
Stamoulis ChristianaEVP & Chief Financial Officer
|
GrantPerformance Shares · Derivative | 27,769 | $0.00 | $0.00 |
DisclosureSEC source: 0000879169-25-000083 · wk-form4_1752696234.xml · derivative · entry 4 Stamoulis Christiana · CIK 0001502917 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,769 Underlying: Common Stock · 27,769 shares Expires 2028-07-15 F4 · derivative.exercise_price: Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return ("TSR") over a three-year performance period beginning on January 1, 2025 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date subject to the Reporting Person's continued service with the issuer. F4 · derivative.exercise_date: Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return ("TSR") over a three-year performance period beginning on January 1, 2025 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date subject to the Reporting Person's continued service with the issuer. Read SEC document |
| July 15, 2025 Filed Jul 16, 2025 20:03 UTC |
Stamoulis ChristianaEVP & Chief Financial Officer
|
GrantCommon Stock | 11,107 | $0.00 | $0.00 |
DisclosureSEC source: 0000879169-25-000083 · wk-form4_1752696234.xml · nonDerivative · entry 3 Stamoulis Christiana · CIK 0001502917 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,759 F2 · shares: Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years. The RSUs may be settled only for shares of common stock on a one-for-one basis. F3 · balance_after: Including the July 15, 2025 grant, this includes an aggregate of 64,006 shares of common stock issuable pursuant to previously reported RSUs and earned performance shares that have not vested. Read SEC document |
| July 15, 2025 Filed Jul 16, 2025 20:03 UTC |
Stamoulis ChristianaEVP & Chief Financial Officer
|
Tax withholdingCommon Stock | 1,445 | $68.25 | $98,621.25 |
DisclosureSEC source: 0000879169-25-000083 · wk-form4_1752696234.xml · nonDerivative · entry 2 Stamoulis Christiana · CIK 0001502917 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 114,652 F1 · shares: Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of RSUs or earned performance shares previously reported in Table I as common stock. Read SEC document |
| July 15, 2025 Filed Jul 16, 2025 20:04 UTC |
SWAIN PAULA JEVP, Human Resources
|
GrantEmployee Stock Option (right to buy) · Derivative | 14,472 | $0.00 Strike: $68.25 | $0.00 |
DisclosureSEC source: 0000879169-25-000084 · wk-form4_1752696274.xml · derivative · entry 5 SWAIN PAULA J · CIK 0001236934 · EVP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,472 Underlying: Common Stock · 14,472 shares Expires 2035-07-14 F5 · derivative.exercise_date: The July 15, 2025 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years. Read SEC document |
| July 15, 2025 Filed Jul 16, 2025 20:04 UTC |
SWAIN PAULA JEVP, Human Resources
|
GrantPerformance Shares · Derivative | 16,077 | $0.00 | $0.00 |
DisclosureSEC source: 0000879169-25-000084 · wk-form4_1752696274.xml · derivative · entry 4 SWAIN PAULA J · CIK 0001236934 · EVP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,077 Underlying: Common Stock · 16,077 shares Expires 2028-07-15 F4 · derivative.exercise_price: Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return ("TSR") over a three-year performance period beginning on January 1, 2025 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date subject to the Reporting Person's continued service with the issuer. F4 · derivative.exercise_date: Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return ("TSR") over a three-year performance period beginning on January 1, 2025 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date subject to the Reporting Person's continued service with the issuer. Read SEC document |
| July 15, 2025 Filed Jul 16, 2025 20:04 UTC |
SWAIN PAULA JEVP, Human Resources
|
GrantCommon Stock | 6,430 | $0.00 | $0.00 |
DisclosureSEC source: 0000879169-25-000084 · wk-form4_1752696274.xml · nonDerivative · entry 3 SWAIN PAULA J · CIK 0001236934 · EVP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 106,482 F2 · shares: Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years. The RSUs may be settled only for shares of common stock on a one-for-one basis. F3 · balance_after: Including the July 15, 2025 grant, this includes an aggregate of 37,390 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested. Read SEC document |
| July 15, 2025 Filed Jul 16, 2025 20:04 UTC |
SWAIN PAULA JEVP, Human Resources
|
Tax withholdingCommon Stock | 563 | $68.25 | $38,424.75 |
DisclosureSEC source: 0000879169-25-000084 · wk-form4_1752696274.xml · nonDerivative · entry 2 SWAIN PAULA J · CIK 0001236934 · EVP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,052 F1 · shares: Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of RSUs or earned performance shares previously reported in Table I as common stock. Read SEC document |
| July 15, 2025 Filed Jul 16, 2025 20:03 UTC |
Tray ThomasPrincipal Accounting Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 3,362 | $0.00 Strike: $68.25 | $0.00 |
DisclosureSEC source: 0000879169-25-000082 · wk-form4_1752696197.xml · derivative · entry 4 Tray Thomas · CIK 0001912317 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,362 Underlying: Common Stock · 3,362 shares Expires 2035-07-14 F4 · derivative.exercise_date: The July 15, 2025 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years. Read SEC document |
| July 15, 2025 Filed Jul 16, 2025 20:03 UTC |
Tray ThomasPrincipal Accounting Officer
|
GrantCommon Stock | 4,482 | $0.00 | $0.00 |
DisclosureSEC source: 0000879169-25-000082 · wk-form4_1752696197.xml · nonDerivative · entry 3 Tray Thomas · CIK 0001912317 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,313 F2 · shares: Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years. The RSUs may be settled only for shares of common stock on a one-for-one basis. F3 · balance_after: Including the July 15, 2025 grant, this includes an aggregate of 15,166 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested. Read SEC document |
| July 15, 2025 Filed Jul 16, 2025 20:03 UTC |
Tray ThomasPrincipal Accounting Officer
|
Tax withholdingCommon Stock | 583 | $68.25 | $39,789.75 |
DisclosureSEC source: 0000879169-25-000082 · wk-form4_1752696197.xml · nonDerivative · entry 2 Tray Thomas · CIK 0001912317 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,831 F1 · shares: Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of restricted stock units previously reported in Table I as common stock. Read SEC document |
| July 15, 2025 Filed Jul 16, 2025 20:02 UTC |
Iyengar Vijay KEVP, GMAPPS
|
GrantEmployee Stock Option (right to buy) · Derivative | 14,472 | $0.00 Strike: $68.25 | $0.00 |
DisclosureSEC source: 0000879169-25-000081 · wk-form4_1752696159.xml · derivative · entry 6 Iyengar Vijay K · CIK 0001670000 · EVP, GMAPPS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 14,472 Underlying: Common Stock · 14,472 shares Expires 2035-07-14 F5 · derivative.exercise_date: The July 15, 2025 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years. Read SEC document |
| July 15, 2025 Filed Jul 16, 2025 20:02 UTC |
Iyengar Vijay KEVP, GMAPPS
|
GrantPerformance Shares · Derivative | 16,077 | $0.00 | $0.00 |
DisclosureSEC source: 0000879169-25-000081 · wk-form4_1752696159.xml · derivative · entry 5 Iyengar Vijay K · CIK 0001670000 · EVP, GMAPPS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,077 Underlying: Common Stock · 16,077 shares Expires 2028-07-15 F4 · derivative.exercise_price: Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return ("TSR") over a three-year performance period beginning on January 1, 2025 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date subject to the Reporting Person's continued service with the issuer. F4 · derivative.exercise_date: Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return ("TSR") over a three-year performance period beginning on January 1, 2025 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date subject to the Reporting Person's continued service with the issuer. Read SEC document |
| July 15, 2025 Filed Jul 16, 2025 20:02 UTC |
Iyengar Vijay KEVP, GMAPPS
|
GrantCommon Stock | 6,430 | $0.00 | $0.00 |
DisclosureSEC source: 0000879169-25-000081 · wk-form4_1752696159.xml · nonDerivative · entry 4 Iyengar Vijay K · CIK 0001670000 · EVP, GMAPPS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 41,523 F2 · shares: Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years. The RSUs may be settled only for shares of common stock on a one-for-one basis. F3 · balance_after: Including the July 15, 2025 grant, this includes an aggregate of 37,752 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested. Read SEC document |
| July 15, 2025 Filed Jul 16, 2025 20:02 UTC |
Iyengar Vijay KEVP, GMAPPS
|
Tax withholdingCommon Stock | 836 | $68.25 | $57,057.00 |
DisclosureSEC source: 0000879169-25-000081 · wk-form4_1752696159.xml · nonDerivative · entry 3 Iyengar Vijay K · CIK 0001670000 · EVP, GMAPPS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 35,093 F1 · shares: Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of RSUs or earned performance shares previously reported in Table I as common stock. Read SEC document |
| July 15, 2025 Filed Jul 16, 2025 20:02 UTC |
Iyengar Vijay KEVP, GMAPPS
|
SaleCommon Stock | 1,177 | $69.86 | $82,225.22 |
DisclosureSEC source: 0000879169-25-000081 · wk-form4_1752696159.xml · nonDerivative · entry 2 Iyengar Vijay K · CIK 0001670000 · EVP, GMAPPS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 35,929 Read SEC document |
| July 15, 2025 Filed Jul 16, 2025 20:02 UTC |
Flannelly Barry PEVP & General Manager US
|
Tax withholdingCommon Stock | 1,141 | $68.25 | $77,873.25 |
DisclosureSEC source: 0000879169-25-000080 · wk-form4_1752696123.xml · nonDerivative · entry 3 Flannelly Barry P · CIK 0001615842 · EVP & General Manager US 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 36,489 F1 · shares: Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of RSUs or earned performance shares previously reported in Table I as common stock. F2 · balance_after: This includes an aggregate of 35,136 shares of common stock issuable pursuant to previously reported RSUs and earned performance shares that have not vested. Read SEC document |
| July 15, 2025 Filed Jul 16, 2025 20:02 UTC |
Flannelly Barry PEVP & General Manager US
|
SaleCommon Stock | 1,192 | $69.86 | $83,273.12 |
DisclosureSEC source: 0000879169-25-000080 · wk-form4_1752696123.xml · nonDerivative · entry 2 Flannelly Barry P · CIK 0001615842 · EVP & General Manager US 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 37,630 Read SEC document |
| July 15, 2025 Filed Jul 16, 2025 20:01 UTC |
Hoppenot HerveDirector · Special Advisor to the CEO
|
Tax withholdingCommon Stock | 4,713 | $68.25 | $321,662.25 |
DisclosureSEC source: 0000879169-25-000079 · wk-form4_1752696081.xml · nonDerivative · entry 2 Hoppenot Herve · CIK 0001596492 · Director · Special Advisor to the CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 517,146 F1 · shares: Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of RSUs or earned performance shares previously reported in Table I as common stock. F2 · balance_after: This includes an aggregate of 73,486 shares of common stock issuable pursuant to previously reported RSUs and earned performance shares that have not vested. Read SEC document |
| July 15, 2025 Filed Jul 17, 2025 20:04 UTC |
Denton Sheila A.EVP & General Counsel
|
GrantEmployee Stock Option (right to buy) · Derivative | 18,419 | $0.00 Strike: $68.25 | $0.00 |
DisclosureSEC source: 0000879169-25-000091 · wk-form4_1752782690.xml · derivative · entry 8 Denton Sheila A. · CIK 0001995298 · EVP & General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 18,419 Underlying: Common Stock · 18,419 shares Expires 2035-07-14 F6 · derivative.exercise_date: The July 15, 2025 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years. Read SEC document |
| July 15, 2025 Filed Jul 17, 2025 20:04 UTC |
Denton Sheila A.EVP & General Counsel
|
GrantPerformance Shares · Derivative | 20,461 | $0.00 | $0.00 |
DisclosureSEC source: 0000879169-25-000091 · wk-form4_1752782690.xml · derivative · entry 7 Denton Sheila A. · CIK 0001995298 · EVP & General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,461 Underlying: Common Stock · 20,461 shares Expires 2028-07-15 F5 · derivative.exercise_price: Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return ("TSR") over a three-year performance period beginning on January 1, 2025 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date subject to the Reporting Person's continued service with the issuer. F5 · derivative.exercise_date: Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return ("TSR") over a three-year performance period beginning on January 1, 2025 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date subject to the Reporting Person's continued service with the issuer. Read SEC document |
| July 15, 2025 Filed Jul 17, 2025 20:04 UTC |
Denton Sheila A.EVP & General Counsel
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,330 | $0.00 Strike: $64.25 | $0.00 |
DisclosureSEC source: 0000879169-25-000091 · wk-form4_1752782690.xml · derivative · entry 6 Denton Sheila A. · CIK 0001995298 · EVP & General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,993 Underlying: Common Stock · 3,330 shares Expires 2034-07-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The July 15, 2024 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years. Read SEC document |
| July 15, 2025 Filed Jul 17, 2025 20:04 UTC |
Denton Sheila A.EVP & General Counsel
|
GrantCommon Stock | 8,184 | $0.00 | $0.00 |
DisclosureSEC source: 0000879169-25-000091 · wk-form4_1752782690.xml · nonDerivative · entry 4 Denton Sheila A. · CIK 0001995298 · EVP & General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,985 F2 · shares: Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years. The RSUs may be settled only for shares of common stock on a one-for-one basis. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.